Home > Information > What's New 2021

What's New 2021

Dec. 24, 2021: Depletion of central memory CD8+T cells might impede the antitumor therapeutic effect of Mogamulizumab
Dec. 23, 2021: Webinar for “Russo -Japanese Joint Symposium”
Dec. 23, 2021: Launch of an Asian international collaborative prospective study on 6 advanced cancers common in Asia
Dec. 21, 2021: CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,
identified using LC-SCRUM-Asia genomic screening platform
Dec. 14, 2021: Endoscopists at the National Cancer Center Hospital selected as world-class experts in endoscopic mucosal resection (EMR) by Expertscape
Dec. 1, 2021: Joint Statement Issued with National Cancer Hospital, Viet Nam
Nov. 22, 2021: Memorandum of Understanding signed with Frederick National Laboratory for Cancer Research
Nov. 15, 2021: Activated WNT/β-catenin pathway induces resistance to immunotherapies in cancers harboring high tumor mutation burden
Nov. 12, 2021: Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer
Nov. 11, 2021: First in-patient transplantation of iPS cell-derived natural killer cells to treat ovarian cancer
Oct. 28, 2021: Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma
Oct. 27, 2021: Global whole genome sequencing research on esophageal cancers reveals
carcinogenic mechanisms specific to Japan
Oct. 27, 2021: For future collaboration of Japan-China-Korea NCCs
Oct. 20, 2021: MASTER KEY ASIA
Oct. 14, 2021: Breakthrough Discovery on the Structure and Activation Mechanism of ALK
Oct. 7, 2021: National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2022　(Oncology)”
Sep. 8, 2021: Shun-ichi Watanabe awarded the Ginsberg Lectureship Award for Surgery at the 2021 World Conference on Lung Cancer
Sep. 6, 2021: Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
Aug. 17, 2021: Whole Genome Sequencing Finds Therapeutic Targets for Linitis Plastica-type Gastric Cancer
Aug. 16, 2021: Webinar with Neijiang, China
Jul. 20, 2021: Japan-China-Korea NCCs Top Meeting
Jun. 30, 2021: Initiation of the 4th-stage industry-academia collaborative Cancer Genome Screening Project for Individualized Medicine in Japan, SCRUM-Japan
Jun. 22, 2021: Webinar with the Fourth Hospital of Hebei Medical University
Jun. 14, 2021: Visit by Young Leaders’ Program from Nagoya University
Jun. 2, 2021: SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
May 27, 2021: MOU concluded with Thai Society of Clinical Oncology (TSCO)
May 17, 2021: "MONSTAR-SCREEN" has joined as an official member program in the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO)
May 14, 2021: NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND　DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
Apr. 27, 2021: National Cancer Center Japan and Pharmaceuticals and Medical Devices Agency Endorsed as a joint Center of Excellence by APEC
Apr. 23, 2021: Cancer Statistics in Japan; Table download
Apr. 9, 2021: Dr Hiroyuki Mano was awarded the 49th Fondation ARC Leopold Griffuel Prize for Clinical and Translational Cancer Research
Mar. 23, 2021: First drug approved for unresectable thymic carcinoma
Feb. 15, 2021: NCC Leadership Courtesy Visit to His Excellency the Ambassador of France
Feb. 2, 2021: Deep Vision: Near-Infrared Imaging and Machine Learning Can Identify Hidden Tumors